XML 29 R15.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 9 - Stock-based Compensation
3 Months Ended
Mar. 31, 2017
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
9.
       Stock-Based Compensation
 
(a) Stock-Based Compensation Expense
 
Total stock-based compensation expense in the Company’s Consolidated Statements of Income related to the Company’s long-term incentive award plans was as follows
(in thousands)
:
 
 
 
Three Months Ended
March 31,
 
 
2017
 
2016
Cost of services-compensation
 
$
2,040
 
 
$
1,931
 
Selling, general and administrative
 
 
3,346
 
 
 
2,309
 
Total
 
$
5,386
 
 
$
4,240
 
 
(b) Stock Options
 
Stock-based compensation expense related to stock options was approximately
$2.1
million and
$2.0
million for the
three
months ended
March 31, 2017
and
2016,
respectively.
 
Presented below is a summary of stock option activity for the
three
months ended
March 31, 2017 (
in thousands except for weighted average exercise price and weighted average remaining contractual terms
):
 
 
 
Number
of
Options
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Terms
 
Aggregate
Intrinsic
Value
Outstanding balance at December 31, 2016
 
 
5,191
 
 
$
17.35
 
 
 
 
 
 
 
 
 
Granted
 
 
-
 
 
 
-
 
 
 
 
 
 
 
 
 
Exercised
 
 
1
 
 
 
2.71
 
 
 
 
 
 
 
 
 
Forfeitures
 
 
(52
)
 
 
18.88
 
 
 
 
 
 
 
 
 
Expired
 
 
(16
)
 
 
24.87
 
 
 
 
 
 
 
 
 
Outstanding balance at March 31, 2017
 
 
5,124
 
 
 
17.32
 
 
 
4.76
 
 
$
20,130
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Expected to vest at March 31, 2017
 
 
1,540
 
 
 
15.01
 
 
 
5.52
 
 
 
8,431
 
Exercisable at March 31, 2017
 
 
2,920
 
 
$
18.99
 
 
 
4.21
 
 
$
8,231
 
 
The weighted-average grant date fair value per share of the stock options granted during the
three
months ended
March 31, 2016
was
$5.45.
No
stock options were issued during the
three
months ended
March 31, 2017.
HMS estimated the fair value of each stock option grant on the date of grant using a Black-Scholes option pricing model and weighted–average assumptions set forth in the following table:
 
    Three Months
Ended March 31,
    2017   2016
Expected dividend yield    
     
 
Risk-free interest rate    
     
1.20
%
Expected volatility    
     
43.89
%
Expected life (years)    
     
4.9
 
 
During the
three
months ended
March 31, 2017
and
2016,
the Company issued
677
and
9,975
shares, respectively, of the Company’s common stock upon the exercise of outstanding stock options and received proceeds of
$1,836
and
$26,425,
respectively. The total intrinsic value of stock options exercised during the
three
months ended
March 31, 2017
and
2016
was
$10,903
and
$100,815,
respectively.
 
As of
March 31, 2017,
there was approximately
$10.2
million of total unrecognized compensation cost related to stock options outstanding, which is expected to be recognized over a weighted average period of
1.11
years.
 
Excess tax benefit from the exercise of stock options for the
three
months ended
March 31, 2017
and
2016
was
$0.4
million and
$0.01
million, respectively.
 
(c) Restricted Stock Units
 
Stock-based compensation expense related to restricted stock units was
$3.3
million and
$2.2
million for the
three
months ended
March 31, 2017
and
2016,
respectively.
 
Presented below is a summary of restricted stock units activity for the
three
months ended
March 31, 2017
(in thousands, except for weighted average grant date fair value per unit):
 
 
 
Number of
Units
 
Weighted Average
Grant Date Fair
Value per Unit
Outstanding balance at December 31, 2016
 
 
1,413
 
 
$
16.44
 
Granted
 
 
4
 
 
 
20.33
 
Vesting of restricted stock units, net of units withheld for taxes
 
 
(332
)
 
 
16.27
 
Units withheld for taxes
 
 
(140
)
 
 
16.27
 
Forfeitures
 
 
(28
)
 
 
17.99
 
Outstanding balance at March 31, 2017
 
 
917
 
 
$
16.51
 
 
As of
March 31, 2017,
761,178
restricted stock units remained unvested and there was approximately
$10.4
million of unrecognized compensation cost related to restricted stock units, which is expected to be recognized over a weighted average vesting period of
1.11
years.